transplant purifi islet cell diabet rat iii immunosuppress effect cyclosporin studi effect cyclosporin surviv islet beta-cel allograft streptozocin stz diabet rat daili oral dose mg/kg agent reject isol islet littl pancreat tissu immunosuppress effect discontinu drug donor tissu nonendocrin content recipi cultur islet normal state wk drug cours case period treatment long-term benefici effect recipi purifi islet beta-cel graft treatment half case cyclosporin mononuclear cell infiltr type islet beta-cel allograft aggreg mix endocrin islet cell infiltr free condit minim initi infiltr long-term graft surviv need continu pharmacolog immunosuppress short-term cyclosporin treatment long-term surviv allograft islet beta-cel graft nonendocrin element rodent suffici immunosuppress cyclosporin level ng/ml concentr cytotox cultur islet beta-cel non-beta-cel treatment immunomodul ciamexon long-term surviv purifi beta-cel allograft cultur islet 